510(k) K223653

BD Vaginal Panel by Becton, Dickinson And Company — Product Code PQA

K223653 is an FDA 510(k) premarket notification submitted by Becton, Dickinson And Company for the device "BD Vaginal Panel". The FDA issued a decision of Substantially Equivalent on Mar 6, 2023. The device falls under product code PQA (Vaginitis And Bacterial Vaginosis Nucleic Acid Detection System), a Class II device regulated under 21 CFR 866.3975. Becton, Dickinson And Company has 330 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Mar 6, 2023
Date Received
Dec 6, 2022
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Vaginitis And Bacterial Vaginosis Nucleic Acid Detection System
Device Class
Class II
Regulation Number
866.3975
Review Panel
MI
Submission Type
510(k)

A vaginitis and bacterial vaginosis nucleic acid detection system is a qualitative in vitro diagnostic device for the direct detection of nucleic acid sequences from microorganisms associated with vaginitis or bacterial vaginosis. The device is indicated for individuals with signs and symptoms of vaginitis or bacterial vaginosis and aids in the diagnosis of these vaginal infections.

Need the full FDA record for Becton, Dickinson And Company? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K223653. Report a data issue: hello@regdatalab.com.